Altimmune, Inc. (ALT) Financial Statements (2023 and Earlier)

Company Profile

Business Address 910 CLOPPER ROAD
GAITHERSBURG, MD 20878
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments190,301215,92337,24033,7198,769220,80615,570
Cash and cash equivalents190,301115,9188,96333,7198,769153,99515,570
Short-term investments 100,00628,277  66,811 
Restricted cash and investments3434346343,534  
Receivables4,02912,3731,6504,47110,168  
Other undisclosed current assets9,7621,9274705489941,4641,657
Total current assets:204,126230,25739,39539,37223,466222,27017,227
Noncurrent Assets
Operating lease, right-of-use asset 904698
Property, plant and equipment1,4481,0571,1041,343603121234
Intangible assets, net (including goodwill)12,41912,82412,73213,85238,7222,3482,348
Goodwill     2,3482,348
Intangible assets, net (excluding goodwill)12,41912,82412,73213,85238,722  
Other noncurrent assets87273129184239 53
Total noncurrent assets:14,73914,85814,66315,37839,5642,4692,636
TOTAL ASSETS:218,865245,11554,05854,75163,030224,73919,862
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4,74412,0203,9234,4563,754201,268771
Accounts payable2,03461218373129927521
Accrued liabilities39611,4083,9054,0833,625100250
Employee-related liabilities2,313      
Taxes payable     3,158 
Interest and dividends payable     197,084 
Debt   7250  
Derivative instruments and hedges, liabilities     1,46516
Restructuring reserve     109382
Business combination, contingent consideration, liability6,090      
Deferred revenue and credits36  
Other liabilities     1211
Other undisclosed current liabilities7,442    1,983999
Total current liabilities:18,27612,0203,9234,5273,840204,8382,179
Noncurrent Liabilities
Long-term debt and lease obligation1,4541,8281,8651,8524,575  
Long-term debt, excluding current maturities1,4541,8281,8651,8524,575  
Liabilities, other than long-term debt 5,3902,750595,9384431,034
Deferred tax liabilities, net595,938  
Restructuring reserve      109
Other liabilities     443433
Business combination, contingent consideration, liability 5,3902,750    
Derivative instruments and hedges, liabilities      492
Total noncurrent liabilities:1,4547,2184,6151,91110,5134431,034
Total liabilities:19,73019,2398,5386,43814,353205,2803,213
Stockholders' equity
Stockholders' equity attributable to parent199,135225,87645,52048,31339,39619,45916,649
Common stock4421276
Additional paid in capital497,342417,338187,915170,208121,65649,323240,367
Accumulated other comprehensive loss(5,040)(5,045)(5,020)(5,040)(4,577)(1) 
Accumulated deficit(293,171)(186,421)(137,376)(116,856)(77,685)(29,870)(223,724)
Other undisclosed stockholders' equity    9,282  
Total stockholders' equity:199,135225,87645,52048,31348,67819,45916,649
TOTAL LIABILITIES AND EQUITY:218,865245,11554,05854,75163,030224,73919,862

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues4,4108,1855,80110,33110,7385,23010,641
Revenue, net10,7385,23010,641
Cost of revenue
(Cost of Goods and Services Sold)
      (300)
Gross profit:4,4108,1855,80110,33110,7385,23010,341
Operating expenses(101,324)(62,984)(27,266)(53,166)(62,784)(16,495)(14,043)
Other undisclosed operating income      300
Operating loss:(96,914)(54,799)(21,465)(42,834)(52,045)(11,264)(3,403)
Nonoperating income (expense)(177)337886(2,487)(19)216,28824
Investment income, nonoperating20332384322748  
Other nonoperating income (expense)(374)2415278688
Interest and debt expense(6)(9)(2)(297)(162) (55)
Other undisclosed income from continuing operations before equity method investments, income taxes      55
Income (loss) from continuing operations before equity method investments, income taxes:(97,096)(54,471)(20,581)(45,618)(52,226)205,024(3,379)
Other undisclosed income from continuing operations before income taxes692297162  
Income (loss) from continuing operations before income taxes:(97,091)(54,462)(20,579)(45,321)(52,064)205,024(3,379)
Income tax expense (benefit) 5,417596,1505,638(11,169)(62)
Net income (loss) attributable to parent:(97,091)(49,044)(20,520)(39,171)(46,425)193,854(3,441)
Preferred stock dividends and other adjustments  (453)(3,308)(4,930)  
Net income (loss) available to common stockholders, diluted:(97,091)(49,044)(20,973)(42,479)(51,355)193,854(3,441)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):(97,091)(49,044)(20,520)(39,171)(46,425)193,854(3,441)
Other comprehensive income    2,998  
Other undisclosed comprehensive income (loss)4(24)20    
Comprehensive income (loss):(97,086)(49,069)(20,500)(39,171)(43,428)193,854(3,441)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (463) (1)230
Comprehensive income (loss), net of tax, attributable to parent:(97,086)(49,069)(20,500)(39,634)(43,428)193,853(3,211)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: